The Power of a Conversation: How One Doorstep Dialogue Changed a Mind
Have you ever had a conversation that completely shifted someone’s perspective? Jennifer Bondio has.
As Lift Louisiana’s new Field Organizer, Jennifer has been knocking on doors in Slidell, sparking deep, transformative conversations about reproductive rights. Recently, she had an experience that perfectly captured the power of listening, understanding, and sharing lived experiences.
BREAKING NEWS: Crisis Pregnancy Center Data Breach
The Unexpected Pregnancy Center may have violated state law by failing to protect clients’ personal health information.
Tips for Holiday Dinner Conversations
Here’s Lift Louisiana’s Holiday Reproductive Rights Tip List to guide you this season.
Misoprostol and Mifepristone Are Now Classified as Controlled Substances in Louisiana
Beginning October 1, 2024, Louisiana’s Act 246 will take effect. This legislation adds mifepristone and misoprostol to the Schedule IV list of controlled dangerous substances
2024 Legislative Wrap-up
The 2024 Louisiana legislative session came to an end on Monday, June 3rd, after 84 days of whirlwind policy debates, life-shattering legislation, and intense political maneuvering.
Supreme Court Punts in Moyle v. United States: A Setback for Reproductive Rights
The U.S. Supreme Court released an order in Idaho v. United States and Moyle v. United States declining to issue an opinion on the central issue these cases raised, which will determine whether Idaho’s restrictive abortion ban can be enforced against people who are in serious medical crisis and need an abortion to stabilize their condition and preserve their health.
Supreme Court Dismisses Baseless Mifepristone Case and Protects Abortion Medication
The Supreme Court of the United States delivered an opinion in FDA v. Alliance for Hippocratic Medicine preserving access to mifepristone, one of the two essential medications used in the abortion pill regimen.
